pyrazinamide has been researched along with Pulmonary Fibrosis in 2 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dulgar, O | 1 |
| Eskazan, AE | 1 |
| Ersen, E | 1 |
| Demiroz, AS | 1 |
| Turna, A | 1 |
| Oz, B | 1 |
| Tuzuner, N | 1 |
| CORPE, RF | 1 |
2 other studies available for pyrazinamide and Pulmonary Fibrosis
| Article | Year |
|---|---|
Pleural tuberculosis in a patient with untreated type 1 Gaucher disease.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Gaucher Disease; Humans; Isonia | 2016 |
CLINICAL ASPECTS, MEDICAL AND SURGICAL, IN THE MANAGEMENT OF BATTEY-TYPE PULMONARY DISEASE.
Topics: Bronchiectasis; Calcification, Physiologic; Drug Resistance; Drug Resistance, Microbial; Epidemiolog | 1964 |